Clinical efficacy of Shuxuetong injection in the treatment of 94 acute stage patients of chronic pulmonary heart disease

ZHENG Jia; WANG Shuquan

doi:10.3969/j.issn.1006-0111.2015.03.021

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To observe the effect of Shuxuetong injection in the improvement of heart and lung function on chronic pulmonary heart disease patients with basic treatment. Methods The control group was given low flow oxygen, sensitive antibiotics for infection control, and other treatments such as cough relief, sputum reduction, and antispasmodic treatment. Treatment group was given 6 ml Shuxuetong injection once a day for 14 days as 1 treatment period. Results The total effective rate of treatment group was 93.75%, while that of total control group was 67.39% (P<0.05) from Chi square test(χ²=11.36, P=0.00). All indexes of blood rheology of treatment group significantly improved compared with self control at an earlier time (P<0.05) and control group (P<0.01). Improvement of the index of pulmonary function between two groups was significant difference(P<0.01). Conclusion Shuxuetong injection as an adjuvant treatment would improve microcirculation, reduce inflammation, and improve patient outcomes. Therapy combined with Shuxuetong injection in the treatment of chronic pulmonary heart disease could significantly improve the efficacy, therefore, which would be worth of clinical use.

Clinical efficacy of Shuxuetong injection in the treatment of 94 acute stage patients of chronic pulmonary heart disease

People's Hospital of Longyou County, Longyou 324400, China

Received Date: 2014-07-07

Rev Recd Date: 2014-12-16

Key words:

Abstract: Objective To observe the effect of Shuxuetong injection in the improvement of heart and lung function on chronic pulmonary heart disease patients with basic treatment. Methods The control group was given low flow oxygen, sensitive antibiotics for infection control, and other treatments such as cough relief, sputum reduction, and antispasmodic treatment. Treatment group was given 6 ml Shuxuetong injection once a day for 14 days as 1 treatment period. Results The total effective rate of treatment group was 93.75%, while that of total control group was 67.39% (P<0.05) from Chi square test(χ²=11.36, P=0.00). All indexes of blood rheology of treatment group significantly improved compared with self control at an earlier time (P<0.05) and control group (P<0.01). Improvement of the index of pulmonary function between two groups was significant difference(P<0.01). Conclusion Shuxuetong injection as an adjuvant treatment would improve microcirculation, reduce inflammation, and improve patient outcomes. Therapy combined with Shuxuetong injection in the treatment of chronic pulmonary heart disease could significantly improve the efficacy, therefore, which would be worth of clinical use.

HTML

Reference (10)

[1]	于泽年,马翠荣,林鹿,等.疏血通注射液治疗慢性肺心病疗效观察[J].中国当代医药,2010, 17(24):67.
[2]	中华医学会呼吸病学分会.慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460.
[3]	吴少祯.常见疾病的诊断与疗效判定标准[M] 北京:中国中医药出版社,1999:207.
[4]	梁中奎,杨彦丽.疏血通注射液治疗高血压性脑出血临床观察[J].临床医学,2012,32(1):57-59.
[5]	孙运霞,李静莉.注射用疏血通的质量标准研究J\].时珍国医国药,2006,17(3):383-384.
[6]	吕飞,王春雷,孙晋民.蚓激酶的研究进展[J].中国实用乡村医生杂志,2014,21(2):25-28.
[7]	李俊福.疏血通注射液治疗慢性肺源性心脏病急性加重期的临床观察[J].中医中药,2013,11(30):190-192.
[8]	张燕,梅同华,吴泽志.疏血通对慢性肺心病急性加重患者红细胞膜黏弹特性的影响[J].生物医学工程学杂志,2012,29(1):134-136.
[9]	郑巧燕.水蛭素及重组水蛭素的研究概况[J].海峡药学,2013,25(8):108-110.
[10]	滕文娇,孙晋民.蚓激酶的药学与临床研究进展[J].西北药学杂志,2011,26(1):69-71.

Message Board

Clinical efficacy of Shuxuetong injection in the treatment of 94 acute stage patients of chronic pulmonary heart disease

doi: 10.3969/j.issn.1006-0111.2015.03.021

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views